DE602004032107D1 - Nell-peptidexpressionssysteme und knochenbildende aktivität des nell-peptids - Google Patents

Nell-peptidexpressionssysteme und knochenbildende aktivität des nell-peptids

Info

Publication number
DE602004032107D1
DE602004032107D1 DE602004032107T DE602004032107T DE602004032107D1 DE 602004032107 D1 DE602004032107 D1 DE 602004032107D1 DE 602004032107 T DE602004032107 T DE 602004032107T DE 602004032107 T DE602004032107 T DE 602004032107T DE 602004032107 D1 DE602004032107 D1 DE 602004032107D1
Authority
DE
Germany
Prior art keywords
nell peptide
bone
making
expression systems
nell1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004032107T
Other languages
English (en)
Inventor
Kang Ting
Shunichi Kuroda
Ben Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/029281 external-priority patent/WO2004024893A2/en
Application filed by University of California filed Critical University of California
Publication of DE602004032107D1 publication Critical patent/DE602004032107D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE602004032107T 2003-02-07 2004-02-09 Nell-peptidexpressionssysteme und knochenbildende aktivität des nell-peptids Expired - Lifetime DE602004032107D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44567203P 2003-02-07 2003-02-07
PCT/US2003/029281 WO2004024893A2 (en) 2002-09-13 2003-09-15 Nell-1 enhanced bone mineralization
PCT/US2004/003808 WO2004072100A2 (en) 2003-02-07 2004-02-09 Nell peptide expression systems and bone formation activity of nell peptide

Publications (1)

Publication Number Publication Date
DE602004032107D1 true DE602004032107D1 (de) 2011-05-19

Family

ID=32869406

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004032107T Expired - Lifetime DE602004032107D1 (de) 2003-02-07 2004-02-09 Nell-peptidexpressionssysteme und knochenbildende aktivität des nell-peptids

Country Status (9)

Country Link
US (3) US7544486B2 (de)
EP (1) EP1594889B1 (de)
JP (1) JP2007524360A (de)
CN (1) CN101018562A (de)
AT (1) ATE504649T1 (de)
CA (1) CA2515208A1 (de)
DE (1) DE602004032107D1 (de)
ES (1) ES2366950T3 (de)
WO (1) WO2004072100A2 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6005088A (en) 1996-03-19 1999-12-21 Otsuka Pharmaceutical Co., Ltd. Human NPIK gene
JP3646191B2 (ja) 1996-03-19 2005-05-11 大塚製薬株式会社 ヒト遺伝子
US7884066B2 (en) 1999-10-05 2011-02-08 The Regents Of The University Of California NELL-1 enhanced bone mineralization
US7687462B2 (en) * 1999-10-05 2010-03-30 The Regents Of The University Of California Composition for promoting cartilage formation or repair comprising a nell gene product and method of treating cartilage-related conditions using such composition
US7544486B2 (en) * 2003-02-07 2009-06-09 The Regents Of The University Of California Nell peptide expression systems and bone formation activity of nell peptide
EP1694352A2 (de) * 2003-11-19 2006-08-30 DeveloGen Aktiengesellschaft Verwendung von sezernierten proteinprodukten zur prävention und behandlung von pankreaserkrankungen und/oder fettsucht und/oder des metabolischen syndroms
US7691607B2 (en) 2004-02-09 2010-04-06 The Regents Of The University Of California Expression system of NELL peptide
CN101115839B (zh) * 2004-08-30 2011-05-04 杨梦甦 通过rh核心蛋白聚糖-Fc融合蛋白抑制纤维发生的方法
CA2597605A1 (en) 2005-02-16 2006-08-24 The Regents Of The University Of California Pharmaceutical compositions for treating or preventing bone conditions
KR20140109509A (ko) * 2006-07-11 2014-09-15 큐피에스 엘엘씨 펩타이드의 지속 방출 전달을 위한 의약 조성물
JP2008212265A (ja) * 2007-03-01 2008-09-18 Niigata Univ 培養人工骨及びその作製方法
AU2008304280B2 (en) 2007-09-28 2013-10-31 Ut-Battelle, Llc Methods for promoting wound healing and muscle regeneration with the cell signaling protein Nell 1
CA2699597C (en) * 2007-09-28 2016-10-11 Ut-Battelle, Llc Treatment of cardiovascular disorders using the cell differentiation signaling protein nell1
EP2214697A4 (de) * 2007-10-30 2011-05-18 Univ California Nell-1-zusammensetzungen
JP2011016723A (ja) * 2007-11-02 2011-01-27 Katayama Kagaku Kogyo Kk 骨及び軟骨形成タンパク質を含有する医薬品及び医療器具
JP5641477B2 (ja) * 2008-08-04 2014-12-17 学校法人昭和大学 Ｎｅｌｌ−１による組織・臓器異所再生制御技術
GB2463474B (en) * 2008-09-11 2012-05-02 Agency Science Tech & Res Therapeutic bone growth and regeneration
CA2739608A1 (en) * 2008-10-07 2010-04-15 The Regents Of The University Of California Recombinant nell protein production
US20110002893A1 (en) * 2008-11-03 2011-01-06 Ut-Battelle, Llc Diagnosis and treatment of congenital heart defects using nell1
WO2010111421A2 (en) * 2009-03-25 2010-09-30 The Regents Of The University Of California Isoform nell-1 peptide
WO2011022071A2 (en) * 2009-08-20 2011-02-24 The Regents Of The University Of California Cardiac compositions
WO2011090971A2 (en) 2010-01-19 2011-07-28 The Trustees Of Columbia University In The City Of New York Osteocalcin as a treatment for male reproductive disorders
WO2011091244A1 (en) * 2010-01-21 2011-07-28 NellOne Therapeutics, Inc. Methods to treat or prevent a skin condition using a nell1 peptide
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8551525B2 (en) 2010-12-23 2013-10-08 Biostructures, Llc Bone graft materials and methods
WO2014152497A2 (en) 2013-03-15 2014-09-25 The Trustees Of Columbia University In The City Of New York Osteocalcin as a treatment for cognitive disorders
EP3027235A1 (de) 2013-07-30 2016-06-08 Musculoskeletal Transplant Foundation Aus einem azellulären weichgewebe gewonnene matrizen und verfahren zur herstellung davon
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
EP3226889A4 (de) 2014-11-19 2018-11-21 The Trustees of Columbia University in the City of New York Osteocalcin zur behandlung von gebrechlichkeit im zusammenhang mit alterung
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US10973953B1 (en) 2016-08-18 2021-04-13 Musculoskeletal Transplant Foundation Methods and compositions for preparing transplant tissue
US10752663B2 (en) 2016-08-29 2020-08-25 NellOne Therapeutics, Inc. Methods and compositions for regenerating tissues
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
EP3852823A4 (de) 2018-09-17 2022-05-04 Rejuvablast LLC Kombinationstransplantate für gewebereparatur- oder regenerationsanwendungen
EP3744356A1 (de) 2019-05-31 2020-12-02 Musculoskeletal Transplant Foundation Aus einem azellulären weichgewebe gewonnene matrizen und verfahren zur herstellung davon
CN110420350B (zh) * 2019-08-28 2021-10-22 深圳先进技术研究院 复合生物玻璃的粘附温敏水凝胶及其制备方法和应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394370A (en) * 1981-09-21 1983-07-19 Jefferies Steven R Bone graft material for osseous defects and method of making same
US4409332A (en) * 1982-01-12 1983-10-11 Jefferies Steven R Collagen-enzyme conjugates that exhibit no inflammatory response and method for making the same
US5468359A (en) * 1988-11-14 1995-11-21 Anthony R. Torres Method of determining presence of an analyte by isoelectric focusing
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5674844A (en) * 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US5674725A (en) * 1991-07-11 1997-10-07 British Technology Group Limited Implant materials having a phosphatase and an organophosphorus compound for in vivo mineralization of bone
US5385887A (en) * 1993-09-10 1995-01-31 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
US5763416A (en) * 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
US5942496A (en) * 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
US6083690A (en) * 1995-06-02 2000-07-04 Osteoscreen, Inc. Methods and compositions for identifying osteogenic agents
US6352972B1 (en) * 1995-06-06 2002-03-05 Marcel E. Nimni Bone morphogenetic proteins and their use in bone growth
US6008208A (en) * 1995-10-23 1999-12-28 Osteoscreen, Inc. Compositions and methods for treating bone deficit conditions
US6048964A (en) * 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US6200606B1 (en) * 1996-01-16 2001-03-13 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration
JP3646191B2 (ja) * 1996-03-19 2005-05-11 大塚製薬株式会社 ヒト遺伝子
US6005088A (en) * 1996-03-19 1999-12-21 Otsuka Pharmaceutical Co., Ltd. Human NPIK gene
US6077987A (en) * 1997-09-04 2000-06-20 North Shore-Long Island Jewish Research Institute Genetic engineering of cells to enhance healing and tissue regeneration
US6462019B1 (en) * 1998-07-10 2002-10-08 Osteoscreen, Inc. Inhibitors of proteasomal activity and production for stimulating bone growth
WO2000009691A2 (en) * 1998-08-10 2000-02-24 Urogenesys, Inc. Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells
US7052856B2 (en) * 1999-10-05 2006-05-30 The Regents Of The University Of California NELL-1 enhanced bone mineralization
US7544486B2 (en) * 2003-02-07 2009-06-09 The Regents Of The University Of California Nell peptide expression systems and bone formation activity of nell peptide
US20030039968A1 (en) 2001-07-10 2003-02-27 Applera Corporation Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
JP2006512292A (ja) 2002-09-13 2006-04-13 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Ｎｅｌｌ−１による骨石灰化の増進
TWI296483B (en) * 2005-12-07 2008-05-01 Marketech Int Corp Apparatus and method for adjusting input image based on characteristics of display system

Also Published As

Publication number Publication date
EP1594889B1 (de) 2011-04-06
US20090226505A1 (en) 2009-09-10
WO2004072100A3 (en) 2007-03-15
EP1594889A4 (de) 2008-03-19
JP2007524360A (ja) 2007-08-30
US8048646B2 (en) 2011-11-01
ES2366950T3 (es) 2011-10-26
US7807787B2 (en) 2010-10-05
US20060292670A1 (en) 2006-12-28
EP1594889A2 (de) 2005-11-16
US20100249376A1 (en) 2010-09-30
CA2515208A1 (en) 2004-08-26
WO2004072100A2 (en) 2004-08-26
US7544486B2 (en) 2009-06-09
ATE504649T1 (de) 2011-04-15
CN101018562A (zh) 2007-08-15

Similar Documents

Publication Publication Date Title
DE602004032107D1 (de) Nell-peptidexpressionssysteme und knochenbildende aktivität des nell-peptids
CY1111225T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c
TW200638934A (en) Heteroaryl compounds as P2Y1 receptor inhibitors
CY1111212T1 (el) Θειικες ενωσεις ως αναστολεις της πρωτεασης σερινης ns3 του ιου της ηπατιτιδας γ
TW200716647A (en) Synthesis of (R)-N-methylnaltrexone
ATE502924T1 (de) Lineare harnstoffmimetika-antagonisten des p2y1- rezeptors zur behandlung von thromboseleiden
DE60229530D1 (de) Substituierte piperazine als modulatoren des melanocortinrezeptors
IL232501A (en) Peptide or polypeptide-resistant protein analogs and their uses
HK1135103A1 (en) Dihydropyridine derivatives useful as protein kinase inhibitors
ATE414089T1 (de) Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust
TWI265927B (en) Novel compounds as NS3-serine protease inhibitors of hepatitis C virus
MY162157A (en) Substituted indole mcl-1 inhibitors
ECSP055584A (es) Proceso para la preparación de fibrinógeno
NO20063196L (no) Nye fusjonerte pyrrolokarbazoler
TW200600506A (en) Substituted morpholine compounds for the treatment of central nervous system disorders
EA201000329A1 (ru) Циклические депсипептиды
GEP20074211B (en) Novel perindopril salt and pharmaceutical compositions containing same
TW200716132A (en) Novel chemical compounds
MY149041A (en) Novel fused pyrrolocarbazoles
WO2003104266A3 (en) PEPTIDES AND PEPTIDOMIMETICS FOR INHIBITING THE ACTIVITY OF THE PROSTAGLANDIN F2 DOLLAR G (A) RECEPTOR
HK1121670A1 (en) Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
DE602005014632D1 (de) Pyrrol- bzw. imidazolamide zur behandlung von obesitas
WO2006052840A3 (en) Bone tropic peptides
TW200738689A (en) Salts and polymorphs of a VEGF-R inhibitor
DE50311756D1 (de) Mikrobizide oxathiincarboxamide